First American Bank Increases Stock Holdings in Amrize Ltd $AMRZ

First American Bank boosted its holdings in shares of Amrize Ltd (NYSE:AMRZ) by 19.4% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 58,572 shares of the company’s stock after buying an additional 9,501 shares during the quarter. First American Bank’s holdings in Amrize were worth $3,281,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Norges Bank acquired a new stake in Amrize in the 4th quarter worth approximately $929,333,000. Harris Associates L P purchased a new stake in Amrize in the fourth quarter valued at $615,406,000. Wellington Management Group LLP boosted its stake in shares of Amrize by 48.8% in the third quarter. Wellington Management Group LLP now owns 11,622,024 shares of the company’s stock worth $561,018,000 after buying an additional 3,809,133 shares during the last quarter. Marshall Wace LLP boosted its position in Amrize by 865.4% in the 3rd quarter. Marshall Wace LLP now owns 2,889,660 shares of the company’s stock worth $139,436,000 after purchasing an additional 2,590,336 shares in the last quarter. Finally, Barclays PLC boosted its holdings in Amrize by 95.4% during the fourth quarter. Barclays PLC now owns 4,614,593 shares of the company’s stock worth $249,557,000 after buying an additional 2,253,431 shares in the last quarter.

Insider Buying and Selling

In related news, CTO Roald Brouwer purchased 1,500 shares of the business’s stock in a transaction that occurred on Thursday, May 21st. The stock was purchased at an average price of $49.84 per share, with a total value of $74,760.00. Following the completion of the acquisition, the chief technology officer owned 19,757 shares in the company, valued at $984,688.88. This trade represents a 8.22% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Mario Gross acquired 1,200 shares of Amrize stock in a transaction that occurred on Wednesday, May 20th. The shares were bought at an average price of $48.63 per share, for a total transaction of $58,356.00. Following the transaction, the insider owned 34,747 shares of the company’s stock, valued at $1,689,746.61. This represents a 3.58% increase in their position. The SEC filing for this purchase provides additional information. Insiders have acquired 54,920 shares of company stock valued at $2,717,429 over the last ninety days. 0.54% of the stock is currently owned by company insiders.

Amrize Stock Performance

AMRZ opened at $54.45 on Thursday. The firm has a market capitalization of $30.12 billion and a PE ratio of 26.05. Amrize Ltd has a twelve month low of $44.12 and a twelve month high of $65.94. The firm’s 50-day moving average price is $53.81 and its 200 day moving average price is $55.67. The company has a current ratio of 1.40, a quick ratio of 0.89 and a debt-to-equity ratio of 0.38.

Amrize (NYSE:AMRZ) last announced its quarterly earnings data on Wednesday, April 29th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by ($0.02). The business had revenue of $2.18 billion for the quarter. Amrize had a net margin of 9.70% and a return on equity of 9.84%. Amrize’s revenue was up 4.7% on a year-over-year basis. As a group, sell-side analysts expect that Amrize Ltd will post 2.75 EPS for the current fiscal year.

Amrize Cuts Dividend

The business also recently declared a dividend, which was paid on Wednesday, May 20th. Stockholders of record on Tuesday, May 12th were given a $0.11 dividend. The ex-dividend date was Tuesday, May 12th. Amrize’s dividend payout ratio is 21.05%.

Wall Street Analyst Weigh In

Several analysts have commented on AMRZ shares. JPMorgan Chase & Co. raised their price objective on Amrize from $60.00 to $70.00 and gave the company an “overweight” rating in a report on Thursday, March 5th. Citigroup decreased their target price on Amrize from $76.00 to $66.00 and set a “buy” rating on the stock in a research report on Monday, May 4th. Weiss Ratings lowered Amrize from a “hold (c+)” rating to a “hold (c)” rating in a research note on Monday, May 18th. Wall Street Zen upgraded Amrize from a “sell” rating to a “hold” rating in a research report on Sunday, March 1st. Finally, Morgan Stanley set a $63.00 price target on Amrize and gave the stock an “overweight” rating in a research report on Monday. One analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and six have given a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $64.71.

About Amrize

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.